Corona in general

Nature Metabolism - Pharmacological inhibitors of fatty acid synthase, including the approved anti-obesity drug orlistat, are shown to inhibit replication of SARS-CoV-2 in vitro and in a mouse...

Nature Communications - Antibodies (Abs) targeting highly conserved epitopes are important tools against emerging virus variants. // 27.9.2021

Researchers from Utrecht University have been investigating the interactions between compliance social distance measurements, infection, and vaccination coverage in order to inform public health policy further. // 28.9.2021

A team of scientists from China and the USA has recently described the antiviral efficacy of a monoclonal antibody candidate targeting the spike receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Importantly, they have observed that emerging spike mutations could not affect the potency of this antibody. / 37.9.2021

Researchers in the UK and Germany have provided evidence for a novel mechanism by which severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – binds to human host cells. // 27.9.2021

A new study discusses the isolation of two variants of concern (VOCs) from an immunocompromised COVID-19 patient. // 27.9.2021

12 UAE hospitals involved in global study // 27.9.2021

Koronarokotteen myötä erittäin tunnetuksi tullut Pfizer testaa lääkettä, jonka ajatuksena on estää koronatartunta sellaisissa henkilöissä, jotka ovat mahdollisesti altistuneet taudille. // 27.9.2021

https://twitter.com/JohnWest_JAWS/status/1442131158066769923?s=20

In a new study, researchers investigate a number of drugs that are believed to potentially worsen outcomes in patients with COVID-19. // 26.9.2021

A team of international scientists has formed a consortium to map the epitope landscape of a range of therapeutic monoclonal antibodies on the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). // 27.9.2021

Japanese scientists created "elite" antibodies that defeat various coronavirus variants even at an extremely low dose through a new method that accelerated the months-long process of finding such extraordinary antibody candidates to just ten days. // 27.9.2021

The study summarized the clinical presentation and demographic features of patients who were hospitalized with COVID-19. // 26.9.2021

In a recent study, researchers conducted a pilot study to assess the prevalence and features of VBTs through the use of sequencing and case data. // 26.9.2021

Within a day of testing positive for covid-19 in June, Miranda Kelly was sick enough to be scared. At 44, with diabetes and high blood pressure, Kelly, a certified nursing assistant, was having trouble breathing, symptoms serious enough to send her to the emergency room. // 24.9.2021

University of Cambridge researchers conducted a study in two repurposed COVID-19 units in Addenbrooke’s Hospital, Cambridge, UK, between January and February 2021. / 24.9.2021

Nature - Studies of bats in China and Laos show southeast Asia is a hotspot for potentially dangerous viruses similar to SARS-CoV-2. // 24.9.2021

The Hydrens team of researchers developed a numerical model that estimates the ozone concentration needed to meet the disinfection criteria. // 24.9.2021

In a study recently published on the medRxiv* preprint server, scientists from Singapore have assessed the levels of IgA-specific anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in the breast milk of women recently immunized with the second dose of an mRNA-based coronavirus disease 2019 (COVID-19) vaccine. // 24.9.2021

Natural infection or vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) confer considerable protection against reinfection and reduce the risk of severe Coronavirus disease 2019 (COVID-19) outcomes. // 24.9.2021

Covid tricks your Immune cell memory to attack the body If given a choice I would take antibodies over cell memory.these articles glaze over this fact of covid in order to beguile the public into forgoing precaution https://t.co/U92gSCBnHQ— Anthony J Leonardi, PhD, MS (@fitterhappierAJ) September 23, 2021

New research suggests SARS-CoV-2 spike protein substitution mutations can create a replication-defective viral particle that makes the virus resistant to vaccine-induced antibodies. // 23.9.2021

A new study finds that environmental factors and human mobility predict seasonal changes in COVID-19 rates, just as in influenza and similar diseases. // 23.9.2021

Researchers from the Genos Glycoscience Research Laboratory in Croatia have recently investigated the sites that the S protein is capable of binding with. // 23.9.2021

There remains a significant need for new and effective drugs that can be used to treat COVID-19. // 23.9.2021

This has become a common refrain among the cautious—and it’s wrong. // 23.9.2021

Nature Communications - There has been limited research on the role of the mucosal immune response to SARS-CoV-2 infection. // 23.9.2021

Researchers from China and Canada recently combined structural data obtained from cryo-EM and structure prediction and constructed bottom-up Martini coarse-grained models of intact envelopes of SARS-CoV and SARS-CoV-2. // 22.9.2021

Researchers from the United States have reviewed the different components of formulated soaps and their performance as cleansers and pathogen inactivators, the criticality of the time spent hand washing, the relationships between water temperature and pathogen inactivation. // 22.9.2021